Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting.
Increase in Cresemba® and Zevtera® related revenue to CHF 80.5 million (+57% year-on-year) Increase in operating profit to CHF 36.9 million and net profit.
Press Release: Basilea reports strong revenue and profit growth in first half-year 2023 finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
Increase in Cresemba® and Zevtera® related revenue to CHF 80.5 million Increase in operating profit to CHF 36.9 million and net profit to CHF 31.9 millionIncrease in cash and restricted cash to CHF. -Today at 01:15 am- MarketScreener